top of page

Thu, Apr 18


Z-Park | ZGC Innovation Center Boston

【 Z-Park x YSA】Frontiers in Precision Medicine

Seminar Topics: NGS Sequencing | Bioinformatics | Clinical Applications

Registration is Closed
See other events
【 Z-Park x YSA】Frontiers in Precision Medicine
【 Z-Park x YSA】Frontiers in Precision Medicine

Time & Location

Apr 18, 2019, 5:30 PM – 7:30 PM

Z-Park | ZGC Innovation Center Boston, 1000 Massachusetts Ave, Cambridge, MA 02138, USA

About the event


Jeff Cheng, Ph.D.

Chief Scientific Officer at Novogene

Talk title: Leading Edge Next-Generation Sequencing and Bioinformatics Services

Jeff Cheng, PhD, is currently the Chief Scientific Officer and Global Head of Biopharmaceutical Services at Novogene Corporation, a global next-generation sequencing and bioinformatics provider.

Prior to joining Novogene, Jeff was the Biomarker Science Leader and China Site Head in the Department of Oncology Biomarker Development at Genentech and Roche Product Development in Asia Pacific. Before that, he was the Head of Scientific Liaison for Biomarker Research at Roche Pharmaceuticals in Shanghai and a Principal Investigator of In Vivo Oncology at BeiGene among other positions.

Jeff obtained his Bachelor’s degree in Chemical Engineering from Tsinghua University in Beijing, China. He then went to Rice University for his PhD in Chemical and Biomolecular Engineering which was followed by a post-doctoral research fellowship at Massachusetts General Hospital and Harvard Medical School. His research there was focused on vascular biology and tumor micro-environment.

Mark Driscoll, Ph.D.

Co-founder and CSO at Shoreline Biome

Mark’s talk will present data that the combination of lysis, PCR design, long readamplicon, and database are key to identifying microbial strains that influence human health.

Dr. Mark Driscoll has led and supported teams launching transformative new sequencing innovations globally since 2000, including teams at 454 Life Sciences that launched the GS20, GS FLX, and the GS Junior Next Generation Sequencing systems. Mark has experience leading the development of hardware, software, informatics and reagents supporting transformative NGS technology advancements. As a co-founder and CSO of Shoreline Biome, Mark has been instrumental in the development of their high throughput DNA preparation and rRNA amplicon NGS kits, including the first all-in-one 16S-23S long read Amplicon kit and 16S-23S database, that, in combination with the PacBio sequencing system, enables differentiation of closely related bacterial strains using high-throughput, long read rRNA gene sequencing. Dr. Driscoll received his Ph.D. in Biochemistry from the University of Rochester.


  • Free




Share this event

bottom of page